Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe for HCV in Liver Transplant Candidates
NCT02768545Phase 4Unknown
- Sponsor
- Pontificia Universidad Católica de Chile
- Start
- Jun 2013
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe in hepatitis C (HCV), sponsored by Pontificia Universidad Católica de Chile. Status: unknown.
02
Drugs
ezetimibe
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02768545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02768545.